Celares GmbH
Home  |  Contact  |  Imprint
celares GmbH celares GmbH celares GmbH celares GmbH celares GmbH
 
 
 

News release

News release

Merck Millipore and celares GmbH
announce collaboration

New: Discrete 4-arm-PEG Maleimide

New: Discrete 4-arm-PEG Maleimide

The multimerisation with discrete 4-arm PEG facilitates defined linker lenght according to binding requirments

Hydrophilic linkers for ADCs

Hydrophilic linkers for ADCs

celares PEG based linker increase solubility of hydrophobic cytotoxic drugs

Technology

PEGylation is an established tool for increasing the tolerance, potency, half-life, and solubility of biopharmaceuticals. celares GmbH offers both proprietary and generic solutions for the modification of biopharmaceuticals with PEG or polymer based reagents.

PEGylation

PEGylation

PEGylation is an effective method for optimizing biopharmaceutical drugs. Coupling with PEG molecules results in considerably greater protease stability, a...

Tetramerisation

Tetramerisation

In the past 10-15 years biologically active agents with antigen binding activity like antibodies, antibody fragments, antibody like molecules, and scaffold...

PEG-peptide conjugates

PEG-peptide conjugates

Multiple sclerosis (MS) is the most common non-traumatic disorder of the central nervous system (CNS) in young adults. It is commonly viewed as an autoimmu...